← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
52 ta ish
Ish: Genetic engineering in oncology based on CRISPR-Cas9 technology
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney +1
Sharh maqolaOchiq kirish20185 iqtibosABICRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp, Kathrin Schumann, Kole T. Roybal +4
MaqolaOchiq kirish20174 iqtibosABICRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu, Zhenguo Zi, Yanling Jin +5
MaqolaOchiq kirish20183 iqtibosABIPhase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
Zhenguang Wang, Na Li, Kaichao Feng +14
MaqolaOchiq kirish20213 iqtibosABICRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi, Xiaoling Yu, Ana P. Castaño +14
MaqolaOchiq kirish20192 iqtibosABINobel Prize 2020 in Chemistry honors CRISPR: a tool for rewriting the code of life
Lukas Westermann, Björn Neubauer, Michael Köttgen
Tahririyat maqolasiOchiq kirish20202 iqtibosABIThe Potential Revolution of Cancer Treatment with CRISPR Technology
Dimitrios Stefanoudakis, Nikhita Kathuria‐Prakash, Alexander W. Sun +10
Sharh maqolaOchiq kirish20232 iqtibosABI